According to our new market research study, titled "Capnography Equipment Market to 2028 - Global Analysis and Forecast - by Product Type, Technology, Application, and End User," the capnography equipment market is expected to grow from US$ 447.59 million in 2021 to US$ 716.38 million by 2028. It is estimated to grow at a CAGR of 7.1% from 2022 to 2028. The report highlights trends prevailing in the capnography equipment market, and drivers and hindrances pertaining to it.

The increasing prevalence of respiratory disorders is driving the demand for capnography equipment. In capnography, infrared radiation is passed over a gas sample collected from exhalation; the carbon dioxide (CO2) content in the sample absorbs infrared radiation. In many cases, oxygen levels in the blood can remain normal for several minutes after a patient stops breathing. The capnography detects the CO2 present in the body with greater accuracy than any other conventional method. The equipment can read every phase of the respiratory cycle, thereby providing more in-depth readings. The ability of capnography machines to provide robust data sets makes it easier for healthcare providers to diagnose the root causes of respiratory problems. The capnograph wavelength shows the entire breathing cycle, making it easier to track exact symptoms. Capnography is used to understand a patient's response to treatment as it can display the ongoing data in real time. The continuous measurement of human respiratory CO2 by using a capnograph provides valuable information about cardiopulmonary resuscitation, endotracheal tube placement, pulmonary embolism, and procedural sedation. The equipment is also used to obtain information about the effect of air pollution on cardiopulmonary characteristics and the effectiveness of a treatment for a patient with respiratory distress. Changes in the shape of s capnogram are used to diagnose respiratory disease conditions, and changes in end-tidal CO2 (EtCO2)-i.e., the maximum CO2 concentration at the end of each tidal breath-can be used to assess disease severity and response to treatment.

North America dominated the capnography equipment market due to the increased prevalence of respiratory disorders and rising technological advancements in capnography devices in the region. The American Heart Association (AHA) recommends the use of capnography monitoring to help physicians to monitor the chest compressions function to confirm endotracheal tube placement and to use as early indicator of the return of spontaneous circulation. The Association for Radiologic and Imaging Nursing (ARIN) supports the use of capnography in patients administered with moderate sedation or analgesia during imaging processes.

According to the Centers for Disease Control and Prevention (CDC), cigarette smoking in the US contributes to 80-90% of lung cancer-related deaths. Further, ~13 of every 100 adults in the country (12.5%) aged 18 years or older had a habit of smoking cigarettes, and ~16 million Americans live with smoking-related diseases. The increasing prevalence of respiratory diseases such as lung cancer, infections, asthma, and COPDs bolster the demand for capnography equipment.

The capnography equipment market experienced a slight decline in the revenue due to disturbed schedules of elective procedures, restrictions on movements of humans and supplies, and delays in supply chains. Medtronic reported a 12% decrease in its cardiac rhythm management device sales in 2020. Similarly, Abbott and Boston Scientific Corp witnessed 10.7% and 12.1% decline, respectively, in the performances of their cardiac rhythm segments in 2020. However, key players experienced a surge in the demand for capnography equipment due to the surge in the incidence of respiratory infections. According to the USFDA, capnography equipment is used in the monitoring of patients during the treatment of COVID-19. Patients provided with an artificial airway as a part of the COVID-19 treatment are monitored through capnography devices. Relaxations in social restrictions and the resumption of nonelective surgeries from 2021 have enabled the revival of the capnography equipment market.

Medtronic, Koninklijke Philips N.V., General Electric Company, Dragerwerk AG & Co. KGaA, Nihon Kohden Corporation, Hill Rom Holding Inc. (Baxter), Masimo, SCHILLER Americas Inc., ICU MEDICAL Inc., and BD are the leading companies operating in the capnography equipment market.

By geography, the capnography equipment market is segmented into North America (US, Canada, and Mexico), Europe (UK, Germany, France, Italy, Spain, and Rest of Europe), Asia Pacific (China, Japan, India, Australia, South Korea, and Rest of Asia Pacific), the Middle East & Africa (UAE, Saudi Arabia, Africa, and Rest of Middle East & Africa), and South & Central America (Brazil, Argentina, and Rest of South and Central America).

Contact Us
Contact Person: Sameer Joshi
Phone: +1-646-491-9876
Email Id: sales@premiummarketinsights.com